Bank of America’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bank of America’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,600	Closed	-$1.3M	–	7962
2023 Q4	$1.3M	Buy	+10,600	New	+$1.32M	﹤0.01%	4786
2017 Q2	–	Sell	-45,000	Closed	-$6.53M	–	7054
2017 Q1	$6.53M	Buy	+45,000	New	+$5.86M	﹤0.01%	2782
2016 Q2	–	Sell	-204,000	Closed	-$26.6M	–	7241
2016 Q1	$26.6M	Buy	+204,000	New	+$25.4M	0.01%	1344
2015 Q1	–	Sell	-900	Closed	-$147K	–	7307
2014 Q4	$147K	Sell	900 -2,300	-72%	-$382K	﹤0.01%	5610
2014 Q3	$514K	Buy	3,200 +1,900	+146%	+$292K	﹤0.01%	4561
2014 Q2	$191K	Sell	1,300 -200	-13%	-$27.7K	﹤0.01%	5597
2014 Q1	$208K	Buy	+1,500	New	+$226K	﹤0.01%	5400
2013 Q4	–	Sell	-25,400	Closed	-$2.34M	–	8008
2013 Q3	$2.34M	Hold	25,400	–	–	﹤0.01%	3114
2013 Q2	$1.75M	Buy	+25,400	New	+$1.55M	﹤0.01%	3376

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Bank of America's JAZZ Position: Q1 2026 in Review

Bank of America increased its Jazz Pharmaceuticals (JAZZ) stake by 11% in Q1 2026, buying an estimated $17.4M and bringing the position to 1,014,800 shares worth $192M. The position accounts for 0.01% of the portfolio, ranked #757.

Bank of America first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. 573 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Bank of America held 1,014,800 shares of Jazz Pharmaceuticals worth $192M as of Q1 2026.
Bank of America bought 99,656 Jazz Pharmaceuticals shares in Q1 2026, an estimated $17.4M.
Jazz Pharmaceuticals made up 0.01% of Bank of America's portfolio in Q1 2026, its #757 holding.
Bank of America first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.